Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The population of Sydney's western suburbs has higher-than-average mortality rates of
heart disease
and has raised prevalence rates of the associated risk factors. To enquire into the
cardiovascular disease
-related knowledge, attitudes and behaviours of this population, a survey that used a multistage area-probability sampling method was conducted in May 1987. A total of 484 subjects was interviewed. The self-reported prevalence rates of angina, heart attacks, strokes and diabetes all were high compared with the rates from the Australia-wide National Heart Foundation's Risk Factor Prevalence Study in 1983. The rates of smoking, hypertension, high blood-lipid levels and sedentary life-style also were raised. Awareness of
cardiovascular disease
-related issues was high but detailed knowledge often was deficient. The majority of respondents reported having attempted to change their health-related behaviours. Of special note was the finding that 80% of current smokers had tried to quit smoking. The high level of awareness of the importance of making life-style changes, and the frequency with which attempts at behavioural changes were reported, suggest that improvements in the health of the population of Sydney's western suburbs will require two complementary strategies: the teaching of the skills that are needed to maintain healthy behaviours successfully and environmental changes to facilitate healthy life-style choices.
...
PMID:Cardiovascular disease-related knowledge and attitudes in a high-risk Australian population. 271 64
The Holter examinations of 111 subjects aged more than 65 who then underwent dynamic ecg were investigated in order to assess the clinical significance of cardiac arrhythmias in geriatric age. Group A was formed of 53 patients with no clinical signs of cardiovascular diseases. Thirty-two patients with clinical evidence of ischaemic
cardiopathy
made up Group B and 26 with arterial hypertension formed Group C. The Holter examinations were evaluated in accordance with current guidelines, considering the basic rhythm, heart rate, pulse formation and conduction disturbances and supraventricular and ventricular hyperkinetic arrhythmias. Sinus base rhythm was present in most cases whereas atrial fibrillation was noted in a similar percentage in the three groups, whether or not
cardiovascular disease
was present. Supraventricular and ventricular hyperkinetic arrhythmias were extremely common in the elderly and made no discrimination between patients with ischaemic
cardiopathy
or hypertension and the clinically healthy; for example, ventricular tachycardia was observed in 10.6% of Group A subjects, in 7.1% of Group B and 8.6% of Group C. To conclude, the clinical significance of heart rhythm changes in the elderly remains obscure because in most subjects they are not related to the presence of
cardiovascular disease
.
...
PMID:[Evaluation of heart rate changes in the aged. An ambulatory electrocardiography study. Arrhythmias in the aged]. 274 42
We investigated the prevalence of stroke in Taiwan in an epidemiologic study of stroke, diabetes, and
cardiovascular disease
that used a two-phase survey design. The study population was drawn by cluster sampling and consisted of both urban and rural communities from four regions of Taiwan. There were 8,705 people 36 years of age or older interviewed during the period of October 1 to December 31, 1986, and 143 cases of completed stroke were later identified by a neurologist. The point prevalence rate for people aged 36 or older in our study was 1,642/100,000 population (95% confidence interval 1,389-1,942/100,000). Prevalence rates differed significantly among the four study regions and between urban and rural communities; prevalence was greater in northern Taiwan and in urban communities. Percentages of the major types of stroke in 143 stroke survivors were as follows: cerebral infarction 67.1% (96 cases), cerebral hemorrhage 14.0% (20 cases), subarachnoid hemorrhage 4.2% (six cases), and unclassified 14.7% (21 cases). Of the stroke survivors, 67.1% were independent in activities of daily living, and 75.5% were independent in ambulation. Hypertension,
heart disease
, diabetes mellitus, and a family history of stroke were significantly more common in stroke survivors than in strokefree individuals.
...
PMID:Prevalence of stroke in Taiwan. 274 45
The associations of self-reported body mass and fat distribution with self-reported prevalence rates of hypertension, heart attack, and other
heart disease
were examined in a sample of 40,000 women, aged 55-69 years. Fat distribution was measured by the waist-to-hip circumference ratio (WHR), which had a mean +/- SD of 0.838 +/- 0.085. Prevalence of hypertension was significantly and positively associated with both body mass index (BMI) and waist-to-hip ratio. The prevalence rate ratio for hypertension in the highest versus the lowest tertile of body mass index and waist-to-hip ratio (considered jointly) was 2.7. Prevalence rates of heart attack and other
heart disease
were significantly and positively associated with waist-to-hip ratio but not with body mass index. The prevalence rate ratios were 2.2 for heart attack and 1.4 for other
heart disease
in the highest versus the lowest tertile of body mass index and waist-to-hip ratio. Findings were substantiated using multiple logistic regression. These results support the hypothesis that a significant relationship exists between body fat distribution and the occurrence of
cardiovascular disease
in older women.
...
PMID:Body fat distribution and self-reported prevalence of hypertension, heart attack, and other heart disease in older women. 276 49
Utah has lower incidence and mortality for many smoking-related forms of cancer and
heart disease
. It is an important epidemiologic question to assess whether the population attributable risk associated with cigarette smoking in this low-risk population is biased from under-reporting because of societal pressures not to smoke. To answer this question, we compared reported cigarette use to serum cotinine values in three different epidemiologic study designs. Included in these analyses were data from men interviewed for a cross-sectional study of dietary intake and hormones, women interviewed as a part of a case-control study of cervical cancer, and men interviewed in conjunction with a
cardiovascular disease
and hypertension family follow-up study. Cross-sectional study participants reported accurate cigarette usage 93.8% of the time; case-control participants accurately reported cigarette use 98.5% of the time; participants interviewed in the family cohort study correctly reported usage 82.8% of the time. Most inaccurate reporting of smoking was by exsmokers being followed for a disease known to be linked to smoking. The low attributable risk of smoking related to diseases in Utah is not from underreporting of cigarette smoking, and makes Utah an ideal population to examine other risk factors for diseases where smoking increases risk.
...
PMID:Validity of cigarette smoking habits in three epidemiologic studies in Utah. 278 67
Goldsmith and Pilpel found the rate of hospitalization for
cardiovascular disease
(
CVD
) in Beer Sheva in 1981 to be approximately twice that of five development towns in the Negev. In order to determine whether this difference was due to differences in the prevalence of
heart disease
, data on
heart disease
mortality hospitalization for 1981, 1983 and 1985 was studied, and hypertension prevalence in these communities were examined. From 1981 death records, age-adjusted
CVD
rates for the male population greater than 30 years were 397.7/100,000 in Beer Sheva and 344.4 in development towns; for women the rates were 351.5 and 411.2, respectively. Myocardial infarction rates for men were the only subset of
CVD
to be significantly different (Beer Sheva 174.3 vs. development towns 115.7). Beer Sheva residents with
CVD
were significantly more likely to die in the hospital or another health care facility than residents of development towns. The rates of emergency room use were higher in Beer Sheva than in development towns, but the proportion of those patients who came to the emergency room because of chest pain who were hospitalized was the same for both communities. Data from a sample study of hypertension recorded for patients in primary care clinics in 1983 showed no differences in prevalence or treatment status between Beer Sheva and development town residents. Overall
CVD
hospitalization rates were 27.7% greater for BS men and 33.3% for BS women. We conclude that: a) the higher rate for myocardial infarction in Beer Sheva merits further investigation, but cannot account for the differential rates of hospital use; and b) distance from the hospital and c) culturally associated attitudes toward hospitalization on the part of both patients and physicians are likely explanations that should be further investigated.
...
PMID:Cardiovascular disease hospitalization rates in Negev communities: are differences due to differential prevalence or differential use of health care? 278 52
It has been postulated that dehydroepiandrosterone (DHEA) and its sulfate ester, dehydroepiandrosterone sulfate (DHEAS), the major secretory products of the human adrenal gland, may be discriminators of life expectancy and aging. We examined the relation of base-line circulating DHEAS levels to subsequent 12-year mortality from any cause, from
cardiovascular disease
, and from ischemic heart disease in a population-based cohort of 242 men aged 50 to 79 years at the start of the study. Mean DHEAS levels decreased with age and were also significantly lower in men with a history of
heart disease
than in those without such a history. In men with no history of
heart disease
at base line, the age-adjusted relative risk associated with a DHEAS level below 140 micrograms per deciliter was 1.5 (P not significant) for death from any causes, 3.3 (P less than 0.05) for death from
cardiovascular disease
, and 3.2 (P less than 0.05) for death from ischemic heart disease. In multivariate analyses, an increase in DHEAS level of 100 micrograms per deciliter was associated with a 36 percent reduction in mortality from any causes (P less than 0.05) and a 48 percent reduction in mortality from
cardiovascular disease
(P less than 0.05), after adjustment for age, systolic blood pressure, serum cholesterol level, obesity, fasting plasma glucose level, cigarette smoking status, and personal history of
heart disease
. Our conclusions are limited by the single determination of DHEAS levels, but the data suggest that the DHEAS concentration is independently and inversely related to death from any cause and death from
cardiovascular disease
in men over age 50.
...
PMID:A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. 294 52
We studied the effect of estrogen use on morbidity from
cardiovascular disease
in 1234 postmenopausal women, aged 50 to 83 years, participating in the Framingham Heart Study's 12th biennial examination (index examination). The medication history recorded at biennial examinations 8 through 12 was used to classify the degree of estrogen exposure before eight years of observation for cardiovascular morbidity and mortality. Despite a favorable cardiovascular risk profile and control for the major known risk factors for
heart disease
, women reporting postmenopausal estrogen use at one or more examinations had over a 50 per cent elevated risk of cardiovascular morbidity (P less than 0.01) and more than a twofold risk for cerebrovascular disease (P less than 0.01) after the index examination. Increased rates for myocardial infarction (P less than 0.05) were observed particularly among the estrogen users who smoked cigarettes. Conversely, among nonsmokers estrogen use was associated only with an increased incidence of stroke (P less than 0.05). No benefits from estrogen use were observed in the study group; in particular, mortality from all causes and from
cardiovascular disease
did not differ for estrogen users and nonusers.
...
PMID:Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. 1462 97
Diet is a component in the etiology of the two major causes of death in the United States, namely,
cardiovascular disease
and cancer. During the last decade, various organizations have suggested that we alter the "typical" American diet in order to decrease the incidence of these diseases even though both diseases are indisputably of multiple etiology. An implication behind these recommendations is that individuals will increase their longevity by changing their diets. The burden of proof falls on those proposing changes to the diet that such alterations will be safe and effective. In spite of our often indicted diet, mortality from
heart disease
and stroke continue to fall and deaths from diet-related cancers are static or dropping. Longevity in the U.S. is exceeded by only five countries, whose populations consume a diet similar to ours in four, and that in the fifth is approaching ours. While low-fat high-fiber diets probably have some beneficial effect vis-a-vis chronic diseases, it is likely that other risk factors contribute more to the total risk of disease. Therefore, it is illogical to expect dietary manipulation to offset significantly other concurrent risks such as heredity, tobacco use, hypertension, and obesity. Individuals who are at high risk for specific diseases should modify their diets to minimize this particular risk factor. Most Americans can safely reduce their intake of total calories, fat, sugar, and salt. Although this can be achieved most readily on a population basis by following a form of "prudent" diet, it is premature to promise medical benefits to individuals.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:The Western diet: an examination of its relationship with chronic disease. 302 70
Two-dimensional and Doppler echocardiography has had a major impact on the diagnostic and therapeutic management of the newborn infant and fetus with a
cardiovascular disorder
. This article illustrates the use of the ultrasound techniques in the diagnosis of
heart disease
in the acyanotic newborn infant with a left-to-right shunt or ventricular outflow obstruction and the cyanotic infant with increased or decreased pulmonary vascularity. In addition, echocardiography has proven invaluable in the in utero diagnosis of cardiovascular abnormalities (structural or rhythm disturbances). This article also reviews the indications for and technical aspects of the fetal echocardiographic examination.
...
PMID:Two-dimensional and Doppler echocardiographic evaluation of heart disease in the neonate and fetus. 306 51
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>